RU2446814C2 - Микроорганизмы молока млекопитающего, их содержащие композиции и их применение для лечения мастита - Google Patents

Микроорганизмы молока млекопитающего, их содержащие композиции и их применение для лечения мастита Download PDF

Info

Publication number
RU2446814C2
RU2446814C2 RU2009149393/15A RU2009149393A RU2446814C2 RU 2446814 C2 RU2446814 C2 RU 2446814C2 RU 2009149393/15 A RU2009149393/15 A RU 2009149393/15A RU 2009149393 A RU2009149393 A RU 2009149393A RU 2446814 C2 RU2446814 C2 RU 2446814C2
Authority
RU
Russia
Prior art keywords
strains
deposited
probiotic
registration number
selection
Prior art date
Application number
RU2009149393/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2009149393A (ru
Inventor
ХИМЕНЕС Росио МАРТИН (ES)
ХИМЕНЕС Росио МАРТИН
МАРТИН Моника ОЛИВАРЕС (ES)
МАРТИН Моника ОЛИВАРЕС
КИНТАНА Эстер Антония ХИМЕНЕС (ES)
КИНТАНА Эстер Антония ХИМЕНЕС
МАРТИНЕС Мария Луиза МАРИН (ES)
МАРТИНЕС Мария Луиза МАРИН
АВИЛА Салета СЬЕРРА (ES)
АВИЛА Салета СЬЕРРА
БАРРАГАН Антонио МАЛЬДОНАДО (ES)
БАРРАГАН Антонио МАЛЬДОНАДО
МЕРИНО Вирхиния МАРТИН (ES)
МЕРИНО Вирхиния МАРТИН
МАРТЕЛЛЬ Франсеск БЛАНЧ (ES)
МАРТЕЛЛЬ Франсеск БЛАНЧ
ЛЬОВЕРАС Селина ТОРРЕ (ES)
ЛЬОВЕРАС Селина ТОРРЕ
ВИЛЛЬОСЛАДА Федерико ЛАРА (ES)
ВИЛЛЬОСЛАДА Федерико ЛАРА
РОДРИГЕС Ребека АРРОЙО (ES)
РОДРИГЕС Ребека АРРОЙО
ПУЭРТА Хулио БОСА (ES)
ПУЭРТА Хулио БОСА
ЛОПЕС Хесус ХИМЕНЕС (ES)
ЛОПЕС Хесус ХИМЕНЕС
АЛЬВАРЕС Леонидес ФЕРНАНДЕС (ES)
АЛЬВАРЕС Леонидес ФЕРНАНДЕС
АБУХА Одон Хулиан СОБРИНО (ES)
АБУХА Одон Хулиан СОБРИНО
ПЕЙ Хорди КСАУС (ES)
ПЕЙ Хорди КСАУС
ГОМЕС Хуан Мигель РОДРИГЕС (ES)
ГОМЕС Хуан Мигель РОДРИГЕС
ПАЛАСИО Сусана ДЕЛЬГАДО (ES)
ПАЛАСИО Сусана ДЕЛЬГАДО
Original Assignee
Пулева Байотек, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пулева Байотек, С.А. filed Critical Пулева Байотек, С.А.
Publication of RU2009149393A publication Critical patent/RU2009149393A/ru
Application granted granted Critical
Publication of RU2446814C2 publication Critical patent/RU2446814C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
RU2009149393/15A 2007-05-31 2008-06-02 Микроорганизмы молока млекопитающего, их содержащие композиции и их применение для лечения мастита RU2446814C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380158A EP1997499A1 (en) 2007-05-31 2007-05-31 Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
EP07380158.1 2007-05-31

Publications (2)

Publication Number Publication Date
RU2009149393A RU2009149393A (ru) 2011-07-10
RU2446814C2 true RU2446814C2 (ru) 2012-04-10

Family

ID=38657070

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009149393/15A RU2446814C2 (ru) 2007-05-31 2008-06-02 Микроорганизмы молока млекопитающего, их содержащие композиции и их применение для лечения мастита

Country Status (16)

Country Link
US (1) US8557560B2 (enExample)
EP (2) EP1997499A1 (enExample)
JP (1) JP5710250B2 (enExample)
AU (1) AU2008257455B2 (enExample)
CA (1) CA2689360C (enExample)
CO (1) CO6270334A2 (enExample)
DK (1) DK2162143T3 (enExample)
ES (1) ES2555159T3 (enExample)
HU (1) HUE025851T2 (enExample)
IL (1) IL202386A0 (enExample)
MX (1) MX2009013044A (enExample)
NZ (1) NZ581576A (enExample)
PL (1) PL2162143T3 (enExample)
PT (1) PT2162143E (enExample)
RU (1) RU2446814C2 (enExample)
WO (1) WO2008145756A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2684600C1 (ru) * 2013-12-19 2019-04-09 Н.В. Нютрисиа Lactobacillus salivarius для лечения мастита
RU2741836C2 (ru) * 2014-10-21 2021-01-29 Акилон Киль Сосьедад Лимитада Композиции пробиотиков и пребиотиков

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
RU2476591C1 (ru) * 2011-08-19 2013-02-27 Федеральное государственное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм enterococcus hirae, используемый для приготовления кисломолочных продуктов
RU2477313C1 (ru) * 2011-08-25 2013-03-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ Enterococcus hirae, ИСПОЛЬЗУЕМЫЙ ПРИ ПРОИЗВОДСТВЕ КИСЛОМОЛОЧНЫХ ПРОДУКТОВ
RU2476592C1 (ru) * 2011-09-02 2013-02-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" Штамм enterococcus hirae, используемый для производства кисломолочных продуктов
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
AU2014256851B2 (en) 2013-04-23 2019-04-18 Terragen Holdings Limited Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
DE102013105666A1 (de) * 2013-06-03 2014-12-04 Hochschule Hannover Probiotische Stämme, Zusammensetzungen enthaltend probiotische Stämme sowie pharmazeutische Mittel
EP2818056A1 (en) 2013-06-25 2014-12-31 Biosearch S.A. Probiotic bacteria comprising metals, metal nanoparticles and uses thereof
US20150057574A1 (en) 2013-08-23 2015-02-26 Elwha Llc Selecting and Delivering Treatment Agents based on a Microbe Profile
US10152529B2 (en) 2013-08-23 2018-12-11 Elwha Llc Systems and methods for generating a treatment map
US9390312B2 (en) 2013-08-23 2016-07-12 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9811641B2 (en) 2013-08-23 2017-11-07 Elwha Llc Modifying a cosmetic product based on a microbe profile
US9557331B2 (en) 2013-08-23 2017-01-31 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9456777B2 (en) 2013-08-23 2016-10-04 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9805171B2 (en) 2013-08-23 2017-10-31 Elwha Llc Modifying a cosmetic product based on a microbe profile
US10010704B2 (en) 2013-08-23 2018-07-03 Elwha Llc Systems, methods, and devices for delivering treatment to a skin surface
PL2862576T3 (pl) 2013-10-16 2017-06-30 Casen Recordati, S.L. Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
PL3065748T3 (pl) 2014-12-23 2018-07-31 4D Pharma Research Limited Szczep Bacteroides thetaiotaomicron i jego zastosowanie w zmniejszaniu zapalenia
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
US20180273895A1 (en) * 2015-01-16 2018-09-27 Biogaia Ab Lactic acid bacteria and their use for the treatment of mastitis
WO2016120405A1 (en) * 2015-01-30 2016-08-04 Technische Universität München Composition for use in preventing and/or treating diarrhea in animals
EP3277255A1 (en) 2015-03-31 2018-02-07 GOJO Industries, Inc. Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EA201890050A1 (ru) 2015-06-15 2018-06-29 4Д Фарма Рисёрч Лимитед Композиции, содержащие бактериальные штаммы
SI3240554T1 (sl) 2015-06-15 2019-12-31 4D Pharma Research Limited, Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni
MD3650033T2 (ro) 2015-06-15 2022-08-31 4D Pharma Res Ltd Compoziții conţinând tulpini bacteriene
SK542015A3 (sk) * 2015-07-30 2017-02-02 Univerzita Pavla Jozefa Šafárika V Košiciach Kmene mikroorganizmov Lactobacillus Plantarum LS/07 CCM 7766 a spôsob ich využitia
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
AU2016357554B2 (en) 2015-11-20 2019-04-04 Cj Bioscience, Inc. Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108495643A (zh) * 2015-12-24 2018-09-04 天天乳品有限公司 新型发酵乳杆菌菌株的组合物和使用方法
EP3520801A1 (en) 2016-03-04 2019-08-07 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
CN110475853A (zh) * 2017-01-13 2019-11-19 益福生医股份有限公司 新颖乳酸菌及其应用
JP7212945B2 (ja) 2017-05-22 2023-01-26 フォーディー ファーマ リサーチ リミテッド 細菌株を含む組成物
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
WO2018229188A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
CN115813955A (zh) 2017-06-14 2023-03-21 4D制药研究有限公司 包含细菌菌株的组合物
MD3804737T2 (ro) 2017-06-14 2022-10-31 4D Pharma Res Limited Compoziții care conțin tulpini bacteriene
JP7436358B2 (ja) * 2018-03-23 2024-02-21 森永乳業株式会社 母乳成分増強用組成物
EP3946608A4 (en) * 2019-03-25 2022-12-28 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) METHODS OF TREATMENT OF BOVINE MASTITIS
EP3996510A4 (en) * 2019-07-08 2023-08-09 BioPlx, Inc. LIVING BIOTHERAPEUTIC COMPOSITIONS AND PROCESSES
EP4065146A1 (en) * 2019-11-29 2022-10-05 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CL2019003739A1 (es) * 2019-12-18 2020-06-19 Univ Concepcion Cepas probióticas de lactobacillus sp. y de pediococcus sp. y su uso en la elaboración de una formulación probiótica para prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos.
JP2022150100A (ja) * 2021-03-26 2022-10-07 清竺 遠藤 乳汁の体細胞数減少用又は乳量増加用組成物
CN117338823A (zh) * 2023-12-06 2024-01-05 山东百德生物科技有限公司 一种动物酵素发酵液及其制备方法与应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046104A1 (en) * 1996-06-05 1997-12-11 Biogaia Biologics Ab Treatment of diarrhea
RU2126446C1 (ru) * 1992-07-06 1999-02-20 Сосьете Де Продюи Нестле С.А. Штамм молочнокислых бактерий lactobacillus acidophilus и композиция против диареи
WO2004003235A2 (en) * 2002-06-28 2004-01-08 Puleva Biotech, S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
WO2005034970A1 (en) * 2003-10-17 2005-04-21 Teagasc The Agriculture And Food Development Authority Use of probiotic bacteria in the treatment of infection
WO2005117532A2 (en) * 2004-06-03 2005-12-15 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591499A (en) 1984-01-20 1986-05-27 J. B. Lima, Inc. Method for treatment and prevention of mastitis
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126446C1 (ru) * 1992-07-06 1999-02-20 Сосьете Де Продюи Нестле С.А. Штамм молочнокислых бактерий lactobacillus acidophilus и композиция против диареи
WO1997046104A1 (en) * 1996-06-05 1997-12-11 Biogaia Biologics Ab Treatment of diarrhea
WO2004003235A2 (en) * 2002-06-28 2004-01-08 Puleva Biotech, S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
WO2005034970A1 (en) * 2003-10-17 2005-04-21 Teagasc The Agriculture And Food Development Authority Use of probiotic bacteria in the treatment of infection
WO2005117532A2 (en) * 2004-06-03 2005-12-15 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2684600C1 (ru) * 2013-12-19 2019-04-09 Н.В. Нютрисиа Lactobacillus salivarius для лечения мастита
RU2741836C2 (ru) * 2014-10-21 2021-01-29 Акилон Киль Сосьедад Лимитада Композиции пробиотиков и пребиотиков

Also Published As

Publication number Publication date
DK2162143T3 (en) 2015-12-14
RU2009149393A (ru) 2011-07-10
CA2689360A1 (en) 2008-12-04
JP2010528093A (ja) 2010-08-19
CO6270334A2 (es) 2011-04-20
EP1997499A1 (en) 2008-12-03
US20100266550A1 (en) 2010-10-21
AU2008257455B2 (en) 2014-05-01
IL202386A0 (en) 2010-06-30
NZ581576A (en) 2012-01-12
MX2009013044A (es) 2010-04-12
PL2162143T3 (pl) 2016-03-31
EP2162143A1 (en) 2010-03-17
HUE025851T2 (en) 2016-04-28
BRPI0811973A2 (pt) 2014-10-21
WO2008145756A1 (en) 2008-12-04
AU2008257455A1 (en) 2008-12-04
ES2555159T3 (es) 2015-12-29
US8557560B2 (en) 2013-10-15
JP5710250B2 (ja) 2015-04-30
EP2162143B1 (en) 2015-09-09
PT2162143E (pt) 2016-01-07
CA2689360C (en) 2017-03-14

Similar Documents

Publication Publication Date Title
JP5710250B2 (ja) 哺乳類乳汁微生物、それらを含有する組成物および乳腺炎の治療のためのそれらの使用
US10842833B2 (en) Lactobacillus plantarum and composition comprising same
JP4176715B2 (ja) プロバイオティクス菌株、その選択方法、その組成物、およびその使用
EP2494031B1 (en) Novel lactobacillus plantarum and composition comprising the same
KR101255894B1 (ko) 락토바실러스 플란타룸 및 그의 용도
CN102597215A (zh) 新型植物乳杆菌及含该植物乳杆菌的组合物
WO2020063531A1 (zh) 副干酪乳杆菌et-22及其用途
EP2220210B1 (en) Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect
CA3123125A1 (en) Strains, composition and method of use
CN115109712A (zh) 德氏乳杆菌乳酸亚种ldl557分离株及其用途
CN117327605A (zh) 一种益生菌制剂及其用途
CN117323298A (zh) 一种长双歧杆菌冻干制剂、其制备方法和用途
CN117327606A (zh) 一种长双歧杆菌菌株及其制备方法和用途
WO2024260437A1 (zh) 一种长双歧杆菌菌株、益生菌制剂及其制备方法和用途
BRPI0811973B1 (pt) Processo para a seleção de probióticos, cepa probiótica, sobrenadante, composição, produto farmacêutico, alimento ou produto nutricional e uso de uma cepa probiótica
HK1122726A (en) A villus elongating agent